| Similar Articles |
|---|
 |
The Motley Fool
August 8, 2005
Stephen D. Simpson |
Do Specialty Chemicals Make Cytec Special? Despite a strong market for specialty chemicals, Cytec trades at a discount to most of its peers.   |
The Motley Fool
January 21, 2005
Stephen D. Simpson |
Cytec Rides the Cycle Specialty chemicals maker Cytec enjoys a strong quarter because of a cyclical run. |
The Motley Fool
November 4, 2005
Stephen D. Simpson |
Cytec Getting the Squeeze Sluggish demand and a move toward higher-margin business are keeping a lid on growth at the chemical manufacturer. |
The Motley Fool
July 19, 2011 |
Cytec Industries Earnings Preview Cytec Industries will unveil its latest earnings on Thursday, July 21. |
The Motley Fool
January 12, 2010
David Lee Smith |
Will 2010 Outclass 2009 for Dow Chemical? Despite a wild year in 2009, Dow Chemical is on fire. |
The Motley Fool
April 6, 2006
Stephen D. Simpson |
RPM Revving Up Maybe things are finally starting to go the right way for specialty chemical companies. Specialty sealants, coatings, and adhesives concern RPM's third quarter sales rose more than 18%, with nearly 11% organic growth. Investors, take note. |
The Motley Fool
May 3, 2006
Stephen D. Simpson |
Cytec Incites Trouble Strength in one segment won't outweigh troubles in the other. This big cyclical company comes with a significant input price risk and minimal pricing power. Investors may want to look elsewhere. |
Chemistry World
July 31, 2015
Phillip Broadwith |
Lightweight composites drive Solvay to buy Cytec The move catapults Solvay into the aerospace materials sector, thanks to Cytec's expertise in lightweight composite materials |
Chemistry World
November 26, 2014
Phillip Broadwith |
UCB sells speciality generics subsidiary Belgian drugmaker UCB has agreed to sell its specialty generics subsidiary, Kremers Urban, to private equity firms Advent International and Avista Capital Partners for $1.5 billion |
